• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手术切除在治疗大肝癌或多结节性肝细胞癌中是否具有作用?

Does surgical resection have a role in the treatment of large or multinodular hepatocellular carcinoma?

作者信息

Ramacciato Giovanni, Mercantini Paolo, Petrucciani Niccolò, Ravaioli Matteo, Cucchetti Alessandro, Del Gaudio Massimo, Cescon Matteo, Ziparo Vincenzo, Pinna Antonio Daniele

机构信息

Department of Surgery, University "Sapienza" of Rome, II Faculty of Medicine, Sant'Andrea Hospital, Rome, Italy.

出版信息

Am Surg. 2010 Nov;76(11):1189-97.

PMID:21140683
Abstract

Several effective treatments are available for patients with small solitary hepatocellular carcinomas (HCCs). Conversely, the management of patients with large or multinodular HCCs is controversial, and the role of surgical resection is not well defined. Between 2000 and 2006, 51 patients with large or multinodular HCC underwent liver resection. Clinicopathologic and follow-up data were prospectively collected and retrospectively reviewed. The perioperative and long-term outcomes were analyzed. Univariate and multivariate analysis of prognostic factors were conducted. Although 20 patients had multinodular HCCs, 31 had large solitary tumors. Perioperative mortality occurred in eight patients and complications in 15. In patients with large solitary tumors, 5-year disease-free and overall survival were 41.3 per cent and 56.1 per cent, respectively. Those with multinodular HCCs demonstrated 5-year disease-free and overall survival rates of 0 per cent and 33.6 per cent, respectively. Liver resection can result in long-term survival in select patients with large or multinodular HCCs, even in select patients with impaired liver function. Large solitary HCCs seem to have better prognoses than multinodular tumors, with lower recurrence and higher survival rates after surgery. Randomized controlled trials comparing resection to other treatment modalities are indicated to determine optimal patient management.

摘要

对于小的孤立性肝细胞癌(HCC)患者,有几种有效的治疗方法。相反,对于大的或多结节性HCC患者的治疗存在争议,手术切除的作用尚不明确。在2000年至2006年期间,51例大的或多结节性HCC患者接受了肝切除术。前瞻性收集并回顾性分析了临床病理和随访数据。分析了围手术期和长期结果。对预后因素进行了单因素和多因素分析。虽然20例患者有多结节性HCC,但31例有大的孤立性肿瘤。8例患者发生围手术期死亡,15例出现并发症。在大的孤立性肿瘤患者中,5年无病生存率和总生存率分别为41.3%和56.1%。多结节性HCC患者的5年无病生存率和总生存率分别为0%和33.6%。肝切除可使部分大的或多结节性HCC患者获得长期生存,即使是部分肝功能受损的患者。大的孤立性HCC似乎比多结节性肿瘤预后更好,术后复发率更低,生存率更高。需要进行比较手术切除与其他治疗方式的随机对照试验,以确定最佳的患者管理方案。

相似文献

1
Does surgical resection have a role in the treatment of large or multinodular hepatocellular carcinoma?手术切除在治疗大肝癌或多结节性肝细胞癌中是否具有作用?
Am Surg. 2010 Nov;76(11):1189-97.
2
Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.米兰标准内小肝细胞癌的手术切除与射频消融治疗对比
J Hepatobiliary Pancreat Surg. 2009;16(3):359-66. doi: 10.1007/s00534-009-0069-7. Epub 2009 Mar 20.
3
Longterm prognosis after hepatic resection for small hepatocellular carcinoma.小肝细胞癌肝切除术后的长期预后
J Am Coll Surg. 2004 Mar;198(3):356-65. doi: 10.1016/j.jamcollsurg.2003.10.017.
4
Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions.巨大肝细胞癌患者初次切除及复发病灶治疗后的结局
Br J Surg. 2007 Mar;94(3):320-6. doi: 10.1002/bjs.5622.
5
The efficacy of liver resection for multinodular hepatocellular carcinoma.多结节肝细胞癌肝切除术的疗效
Anticancer Res. 2014 May;34(5):2421-6.
6
Outcomes of hepatic resection for a single large hepatocellular carcinoma.单个大肝细胞癌肝切除的结果
World J Surg. 2007 Apr;31(4):795-801. doi: 10.1007/s00268-006-0359-z.
7
Long-term results of hepatic resection combined with intraoperative local ablation therapy for patients with multinodular hepatocellular carcinomas.肝切除术联合术中局部消融治疗多结节性肝细胞癌的长期疗效。
Ann Surg Oncol. 2009 Dec;16(12):3299-307. doi: 10.1245/s10434-009-0721-0. Epub 2009 Oct 14.
8
Accompanying liver cirrhosis as a risk factor for recurrence after resection of solitary hepatocellular carcinoma.伴有肝硬化作为孤立性肝细胞癌切除术后复发的一个危险因素。
Hepatogastroenterology. 2003 Nov-Dec;50(54):1991-5.
9
Is liver resection justified in advanced hepatocellular carcinoma? Results of an observational study in 464 patients.晚期肝细胞癌行肝切除术是否合理?464例患者的观察性研究结果
J Gastrointest Surg. 2009 Jul;13(7):1313-20. doi: 10.1007/s11605-009-0903-x. Epub 2009 May 6.
10
Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.肝细胞癌根治性切除术后复发的预后因素评估。
World J Gastroenterol. 2014 Dec 7;20(45):17132-40. doi: 10.3748/wjg.v20.i45.17132.

引用本文的文献

1
Machine Learning-Based Nomogram for Predicting Overall Survival in Elderly Patients with Cirrhotic Hepatocellular Carcinoma Undergoing Ablation Therapy.基于机器学习的列线图预测接受消融治疗的老年肝硬化肝细胞癌患者的总生存期
J Hepatocell Carcinoma. 2024 Mar 7;11:509-523. doi: 10.2147/JHC.S450825. eCollection 2024.
2
Long-term outcomes of liver resection for multiple hepatocellular carcinomas: Single-institution experience with 187 patients.多灶性肝细胞癌肝切除的长期疗效:单中心187例患者的经验
Ann Hepatobiliary Pancreat Surg. 2020 Nov 30;24(4):437-444. doi: 10.14701/ahbps.2020.24.4.437.
3
Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients.
开发和验证一种新的基于肿瘤的基因特征,预测 HBV/HCV 相关性肝癌患者的预后。
J Transl Med. 2019 Jun 18;17(1):203. doi: 10.1186/s12967-019-1946-8.
4
Systematic review of the outcomes of surgical resection for intermediate and advanced Barcelona Clinic Liver Cancer stage hepatocellular carcinoma: A critical appraisal of the evidence.巴塞罗那临床肝癌中晚期肝细胞癌手术切除结果的系统评价:证据的批判性评估
World J Hepatol. 2018 Jun 27;10(6):433-447. doi: 10.4254/wjh.v10.i6.433.
5
Controversies and evidence of hepatic resection for hepatocellular carcinoma.肝细胞癌肝切除的争议与证据
BBA Clin. 2016 Oct 11;6:125-130. doi: 10.1016/j.bbacli.2016.10.001. eCollection 2016 Dec.
6
Hepatic resection as a safe and effective treatment for hepatocellular carcinoma involving a single large tumor, multiple tumors, or macrovascular invasion.肝切除术是治疗涉及单个大肿瘤、多个肿瘤或大血管侵犯的肝细胞癌的一种安全有效的方法。
Medicine (Baltimore). 2015 Jan;94(3):e396. doi: 10.1097/MD.0000000000000396.
7
Hepatic resection associated with good survival for selected patients with multinodular hepatocellular carcinoma.对于部分多结节肝细胞癌患者,肝切除可带来良好的生存率。
Tumour Biol. 2014 Sep;35(9):8355-8. doi: 10.1007/s13277-014-2571-z. Epub 2014 Sep 9.
8
Clinical characteristics and survival of European patients with resectable large hepatocellular carcinomas.可切除性大肝细胞癌欧洲患者的临床特征与生存情况
J Gastrointest Cancer. 2013 Sep;44(3):329-35. doi: 10.1007/s12029-013-9523-5.
9
Patients with multiple hepatocellular carcinomas within the UCSF criteria have outcomes after curative resection similar to patients within the BCLC early-stage criteria.符合 UCSF 标准的多个肝细胞癌患者在根治性切除术后的结局与 BCLC 早期标准内的患者相似。
World J Surg. 2012 Aug;36(8):1811-23. doi: 10.1007/s00268-012-1601-5.